title: [Contributions to the treatment of atypical forms of age-related macular degeneration].
abstract: We performed a study of the two clinical entities with a differential diagnosis with wet age-related macular degeneration, namely, idiopathic polypoidal choroidal vasculopathy (IPCV) and retinal angiomatous proliferation. We analyze the clinical and funduscopic characteristics of these entities as well as their differences with wet age-related macular degeneration. We present two cases that are representative of these two entities. The therapeutic possibilities, results and the latest publications are analyzed and compared. A statistical analysis of the latest publications is also presented.
authors: Unidad de Mácula, Servicio de Oftalmología, Hospital Universitario Virgen Macarena, Sevilla, España; Sociedad Española de Retina y Vítreo (SERV). Electronic address: eduardoesteb@hotmail.com.
authors: E
authors: E
authors: Esteban González
authors: E
authors: E
authors: Cervera Taulet
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D002196:Capillaries / Q000187:drug effects / Q000473:pathology; D002829:Choroid / Q000098:blood supply; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D005451:Fluorescein Angiography; D006801:Humans; D017075:Laser Coagulation; D008297:Male; D009887:Ophthalmoscopy; D010778:Photochemotherapy; D000069579:Ranibizumab; D012171:Retinal Vessels / Q000187:drug effects / Q000473:pathology; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors / Q000502:physiology; D057135:Wet Macular Degeneration / Q000145:classification / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
chemical_list: D000305:Adrenal Cortex Hormones; D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D000069579:Ranibizumab